Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Sep
28
2023
Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] Epstein Becker & Green, P.C.
Apr
22
2020
California Governor Mandates Supplemental Paid Sick Leave for Food Sector Workers at Companies with 500 or More Employees Epstein Becker & Green, P.C.
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Feb
6
2024
Unpacking Averages: Device Manufacturers Should Use the Newly Released Demographic Data in MDRs to Ensure Their Devices Are Not Disproportionately Hurting Minorities Epstein Becker & Green, P.C.
Jul
13
2020
Federal Courts Say They Will Decide Cases Against CBD Product Manufacturers When the Smoke Clears Epstein Becker & Green, P.C.
Mar
5
2024
SAMHSA Final Rule Regarding OTPs Expands Access, Increases Flexibility for Patients Epstein Becker & Green, P.C.
Feb
12
2021
Bias in Healthcare Algorithms Epstein Becker & Green, P.C.
Jul
21
2017
Are Zero Tolerance Drug Testing Policies About to Go Up in Smoke? Epstein Becker & Green, P.C.
Nov
8
2017
FDA Issues Final Regulations Easing the Path for Direct-to-Consumer Genetic Testing Epstein Becker & Green, P.C.
Jun
29
2018
Recreational Marijuana in Massachusetts: What Should Employers Know? Epstein Becker & Green, P.C.
Oct
16
2018
New Draft Guidance on Adaptive Designs for Clinical Trials Epstein Becker & Green, P.C.
Nov
26
2018
Can I Bring Cannabis from Canada Home? Epstein Becker & Green, P.C.
Apr
14
2022
Entrepreneurship in Biotech: Growing Your Business – Diagnosing Health Care [VIDEO] Epstein Becker & Green, P.C.
Jun
23
2022
CMS Reduces COVID-19 Vaccine Mandate Surveys and Rescinds Surveyor Vaccination Requirements Epstein Becker & Green, P.C.
May
16
2019
FDA Declines to Ban Breast Implants, Will Require Full MDR Reporting by Manufacturers Epstein Becker & Green, P.C.
Jun
18
2019
Employer Insights: Recreational Marijuana in Illinois Epstein Becker & Green, P.C.
Mar
14
2023
FDA Introduces Dietary Supplement Ingredient Directory Epstein Becker & Green, P.C.
Nov
22
2019
Limitations on Pre-Employment Testing for Marijuana Epstein Becker & Green, P.C.
Feb
2
2016
FDA Recommends Medical Device Manufacturers Implement a Comprehensive Cybersecurity Risk Management Program in Accordance with NIST Standards Epstein Becker & Green, P.C.
Jul
13
2023
The 2023 DOJ Health Care Fraud Enforcement (f/k/a “Takedown”): Big Dollars or Clever Packaging? Epstein Becker & Green, P.C.
Mar
19
2020
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
28
2020
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances Epstein Becker & Green, P.C.
Nov
29
2023
In Genesis Case, South Carolina District Court Scraps HRSA Interpretation of “Patient” Under 340B Statute Epstein Becker & Green, P.C.
Dec
5
2023
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic Epstein Becker & Green, P.C.
Mar
5
2024
Unpacking Averages: Analyzing FDA’s Performance in Finalizing Guidance Documents Epstein Becker & Green, P.C.
Apr
3
2019
FDA Commissioner Gottlieb Says Agency Will Not Tolerate Deceptive Marketing of CBD Products; Issues Warning Letters Epstein Becker & Green, P.C.
Aug
29
2019
Will the Growing Acceptance of Cannabis Send Drug-Screening Policies Up in Smoke? Epstein Becker & Green, P.C.
Mar
24
2020
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Oct
24
2023
DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 Epstein Becker & Green, P.C.
Jan
5
2024
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy Epstein Becker & Green, P.C.
Feb
27
2024
FDA Releases Updated Directory on Select Dietary Supplement Ingredients Epstein Becker & Green, P.C.
Jan
10
2017
New Federal and State Initiatives Seek to Combat Antimicrobial Resistance Epstein Becker & Green, P.C.
Mar
20
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Procedures, Timelines Epstein Becker & Green, P.C.
May
14
2024
Litigating Nutrition: Class Action Battles Over Dietary Supplements [Podcast, Video] Epstein Becker & Green, P.C.
Jun
7
2017
Growing Questions About Employee Medical Marijuana Use Leave Employers in a Haze Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins